Literature DB >> 1822954

Ototoxicity of cis-platinum and its relationship to eye colour.

R M Barr-Hamilton1, L M Matheson, D G Keay.   

Abstract

The following hypothesis is presented: that the susceptibility of an individual patient to hearing loss as a result of cis-platinum administration can be predicted on the basis of eye colour. The rationale is that the melanin content of the inner ears is related to that of the eyes; dark eyes contain more melanin than light-coloured eyes; and melanin causes the accumulation of the ototoxic drug within the inner ear. Hence those with dark eyes will suffer greater damage to the hearing than those with pale eyes. An investigation that confirmed this hypothesis is reported. In addition to cochlear damage there is a significant likelihood of damage to the auditory nerve as a result of the treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1822954     DOI: 10.1017/s0022215100114689

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  7 in total

Review 1.  A Review of Cisplatin-Associated Ototoxicity.

Authors:  Jessica Paken; Cyril D Govender; Mershen Pillay; Vikash Sewram
Journal:  Semin Hear       Date:  2019-04-26

2.  [Cisplatin-induced hearing loss in children in relation to eye color].

Authors:  H C Martin; C M Schmidt; H J Boos; A Heinecke; A G Dinnesen
Journal:  HNO       Date:  2007-06       Impact factor: 1.284

3.  Application of a neuroprotective ACTH(4-9) analog to affect cisplatin ototoxicity: an electrocochleographic study in guinea pigs.

Authors:  F P Hamers; S F Klis; W H Gispen; G F Smoorenburg
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

4.  Prevalence of hearing loss in Black and White elders: results of the Cardiovascular Health Study.

Authors:  Sheila R Pratt; Lewis Kuller; Evelyn O Talbott; Kathleen McHugh-Pemu; Alhaji M Buhari; Xiaohui Xu
Journal:  J Speech Lang Hear Res       Date:  2009-04-20       Impact factor: 2.297

Review 5.  Experimental, clinical and preventive aspects of ototoxicity.

Authors:  A A Chiodo; P W Alberti
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

Review 6.  Cisplatin-Associated Ototoxicity: A Review for the Health Professional.

Authors:  Jessica Paken; Cyril D Govender; Mershen Pillay; Vikash Sewram
Journal:  J Toxicol       Date:  2016-12-27

7.  Audiological findings in patients treated with radiotherapy for head and neck tumors.

Authors:  Ana Helena Bannwart Dell'Aringa; Myrian de Lima Isaac; Gustavo Viani Arruda; Alfredo Rafael Dell'Aringa; Maria Carolina B N Esteves
Journal:  Braz J Otorhinolaryngol       Date:  2010 Jul-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.